That unsettling experience is at the center of a harrowing New York Times article from Dani Blum, with poison control centers fielding significantly more calls related to compounded drugs like semaglutide this year, compared to all of 2023.
Patients resorting to buying compounded weight-loss drugs may fail to follow instructions, leading to overdosing. FDA warns of gastrointestinal effects, fainting, dehydration, and more from compounded semaglutide overdoses.
Collection
[
|
...
]